Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine – A randomized clinical trial

Authors:

Abstract
No abstract available
Funding Information
  • Quebec Ministry of Health and Social Services
  • Bill and Melinda Gates Foundation

This publication has 33 references indexed in Scilit: